Induction Chemotherapy for Locally Recurrent Rectal Cancer

Clinical Trial Summary

This is a multicentre, open-label, parallel arms, phase IIII study that randomises patients with locally recurrent rectal cancer in a 1:1 ratio to receive either induction chemotherapy followed by neoadjuvant chemoradiotherapy and surgery (experimental arm) or neoadjuvant chemoradiotherapy and surgery alone (control arm)

See also
Status	Clinical Trial	Phase
Completed	`NCT01987726` - Comprehensive Gene Sequencing in Guiding Treatment Recommendations Patients With Metastatic or Recurrent Solid Tumors
Active, not recruiting	`NCT00826540` - Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer	Phase 2
Completed	`NCT00025337` - Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated	Phase 3
Recruiting	`NCT04642924` - SGM-101 in Locally Advanced and Recurrent Rectal Cancer	Phase 2/Phase 3
Completed	`NCT01846520` - Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers	N/A
Completed	`NCT01217450` - Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors	Phase 1
Completed	`NCT01191684` - Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer	Phase 1
Terminated	`NCT01233505` - Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors	Phase 1
Terminated	`NCT01285102` - Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal Cancer	Phase 1
Terminated	`NCT01238965` - Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy	Phase 1
Completed	`NCT01037790` - Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer	Phase 2
Completed	`NCT00551421` - Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer	Phase 1/Phase 2
Completed	`NCT00407654` - VEGF Trap in Treating Patients With Previously Treated Metastatic Colorectal Cancer	Phase 2
Completed	`NCT00091182` - Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment	Phase 2
Terminated	`NCT00052585` - Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer	Phase 2
Completed	`NCT00023933` - Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal Cancer	Phase 1
Not yet recruiting	`NCT05076305` - PelvEx 4: Advanced Pelvic Malignancy and the Role of the Multi-disciplinary Team Meeting
Completed	`NCT01740648` - Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal Cancer	Phase 1
Terminated	`NCT00397878` - AZD0530 (NSC 735464) in Treating Patients With Previously Treated Metastatic Colon Cancer or Rectal Cancer	Phase 2
Completed	`NCT00100841` - Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer	Phase 2

NCT number	NCT04389086
Study type	Interventional
Source	Catharina Ziekenhuis Eindhoven
Contact	Stefi Nordkamp, MD
Phone	0031 40 2398858
Email	stefi.nordkamp@catharinaziekenhuis.nl
Status	Recruiting
Phase	Phase 3
Start date	November 13, 2020
Completion date	March 1, 2030

Induction Chemotherapy for Locally Recurrent Rectal Cancer — PelvEx II

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms